Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Isr J Health Policy Res ; 7(1): 43, 2018 07 31.
Artigo em Inglês | MEDLINE | ID: mdl-30064503

RESUMO

BACKGROUND: Fiscal policies to fight obesity such as taxation of unhealthy foods or sugar-sweetened beverages (SSBs) have gained considerable attention in recent years. Many studies modelling the impact of various magnitudes of taxes on SSB purchasing and their potential effects on various health outcomes have been published; however, legislation and implementation of such taxes have encountered many obstacles in the countries that have implemented them to date. We investigated the perceptions and views of key opinion leaders, policy makers and various other Israeli stakeholders on taxation of SSBs and unhealthy snacks. We also evaluated the challenges and barriers that may be expected for initiating such a policy. METHODS: A qualitative study based on 39 in-depth interviews with Israeli stakeholders in the fields of health, nutrition, economics, public advocacy and policymaking. RESULTS: All stakeholders viewed obesity as a combined societal and personal issue that should be under government responsibility. Only stakeholders from economic sectors thought that taxation of SSBs and unhealthy snacks would reduce their consumption, while the prevailing notion among non-economists was that such a tax would not be acceptable because the higher price would not decrease consumption. Concerns were raised that the tax would mostly affect individuals from low socioeconomic backgrounds. Some of the stakeholders indicated that they would support such a tax only if its revenue would be directed to specific causes such as health-promoting plans. Potential barriers to taxation include: opposition of various sectors, technical and bureaucratic obstacles impeding tax implementation, difficulties in defining which products to tax, and opposition of the treasury to earmark tax revenue for health education. CONCLUSIONS: Taxation should be a part of a multipronged strategy rather than a sole measure for fighting obesity. Dedicating tax revenues to specific predefined causes should be considered, particularly towards health promotion activities, obesity treatment and prevention, education, and subsidies of healthy food.


Assuntos
Bebidas/economia , Alimentos/economia , Edulcorantes/economia , Impostos/legislação & jurisprudência , Promoção da Saúde/métodos , Humanos , Entrevistas como Assunto , Obesidade/prevenção & controle , Formulação de Políticas , Política Pública , Pesquisa Qualitativa
2.
Int J Biochem Cell Biol ; 53: 151-61, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24842104

RESUMO

The circadian clock influences nearly all aspects of metabolism. However, little is known regarding the effect of the energy status on circadian rhythms. Our aim was to test the effect of two opposing energy situations, metformin and lipid emulsion (LE), on clock and metabolic circadian expression in differentiated C2C12 myotubes. Metformin treatment led to depleted ATP levels accompanied by elevated NADH levels, whereas LE treatment led to increased ATP and NAD(+) levels. Nevertheless, both LE and metformin treatments activated the AMP-activated protein kinase (AMPK) pathway. In contrast, the effect on circadian rhythms was completely different. LE led to disrupted clock and metabolic gene expression, whereas metformin led to mainly high-amplitude shifted rhythms. Combination of metformin and LE led to an antagonistic effect on circadian gene expression. Although metformin and LE have an opposing effect on circadian gene expression and on the cellular energy status, they both lead to AMPK activation.


Assuntos
Diferenciação Celular/efeitos dos fármacos , Ritmo Circadiano/genética , Metabolismo Energético/efeitos dos fármacos , Células Musculares/metabolismo , Proteínas Quinases Ativadas por AMP/biossíntese , Animais , Diferenciação Celular/genética , Ritmo Circadiano/efeitos dos fármacos , Emulsões/administração & dosagem , Metabolismo Energético/genética , Regulação da Expressão Gênica no Desenvolvimento/efeitos dos fármacos , Lipídeos/administração & dosagem , Metformina/administração & dosagem , Camundongos , Células Musculares/efeitos dos fármacos , Fibras Musculares Esqueléticas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...